Haleon PLC closed 6.80% below its 52-week high of £4.18, which the company reached on March 4th.

In a key development for Pakistan’s pharmaceutical sector, Haleon Pakistan Limited, formerly known as GlaxoSmithKline ...

Haleon CEO Brian McNamara says his company is not as exposed as peers to tariff risks, as the consumer healthcare company ...

Haleon Pakistan Limited has announced its first international shipment of locally manufactured Centrum multivitamins to Kenya ...

Haleon's dividend grew 10% and is well-covered by FCF, but the 1.6% yield is less attractive compared to peers. See why I ...

Hsbc Global Res lowered shares of Haleon (NYSE:HLN – Free Report) from a strong-buy rating to a hold rating in a research ...

Haleon is one of the largest consumer healthcare companies in the world. Over the last few years, Haleon has achieved a more rationalized operation by divesting multiple non-strategic brands ...

Haleon HLN-1.12%decrease; red down pointing triangle posted a higher pretax profit for 2024 despite lower revenue, and said it expected further organic revenue and profit growth this year.

Haleon posted £11.23B in FY24 revenue, with 5% organic growth. 2025 guidance expects 4-6% organic growth, with profit gains ...

HSBC analyst Jeremy Fialko downgraded Haleon (HLN) to Hold from Buy with a 420 GBp price target Discover the Best Stocks and Maximize Your ...

Berenberg Bank analyst Bethan Davies reiterated a Buy rating on Haleon PLC (HLN – Research Report) on February 28 and set a price target of ...

Shares of Haleon PLC HLN slid 3.40% to £4.01 Wednesday, on what proved to be an all-around dismal trading session for the ...